Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna Parente Ribes"'
Autor:
Audun Os, Simone Bürgler, Anna Parente Ribes, Ane Funderud, Dong Wang, Keith M. Thompson, Geir E. Tjønnfjord, Bjarne Bogen, Ludvig A. Munthe
Publikováno v:
Cell Reports, Vol 4, Iss 3, Pp 566-577 (2013)
There is increasing interest in the chronic lymphocytic leukemia (CLL) microenvironment and the mechanisms that may promote CLL cell survival and proliferation. A role for T helper (Th) cells has been suggested, but current evidence is only circumsta
Externí odkaz:
https://doaj.org/article/e93e963acec147dbbab6bb8c9617a273
Autor:
Anna Parente-Ribes, Sigrid S. Skånland, Simone Bürgler, Audun Os, Dong Wang, Bjarne Bogen, Geir E. Tjønnfjord, Kjetil Taskén, Ludvig A. Munthe
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Externí odkaz:
https://doaj.org/article/31fc6056a55b480f9f0f9a3ca55d48c4
Autor:
Anna Parente-Ribes, Yngvar Fløisand, Simone Bürgler, Bjarne Bogen, Fredrik Schjesvold, Kjetil Taskén, C V Myklebust, Geir E. Tjønnfjord, Ludvig A. Munthe, Anders Aune Tveita, Dong Wang, Peter O. Hofgaard, J. Dalgaard
Multiple myeloma (MM) is a plasma cell malignancy where MM cell growth is supported by the bone marrow (BM) microenvironment with poorly defined cellular and molecular mechanisms. MM cells express CD40, a receptor known to activate autocrine secretio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14d800901c013e3ceda54b7c6ab7224
http://hdl.handle.net/10852/64141
http://hdl.handle.net/10852/64141
Autor:
Geir E. Tjønnfjord, Keith M. Thompson, Audun Os, Simone Bürgler, Anna Parente Ribes, Ludvig A. Munthe, Ane Funderud, Bjarne Bogen, Dong Wang
Publikováno v:
Cell reports
Cell Reports, Vol 4, Iss 3, Pp 566-577 (2013)
Cell Reports, Vol 4, Iss 3, Pp 566-577 (2013)
SummaryThere is increasing interest in the chronic lymphocytic leukemia (CLL) microenvironment and the mechanisms that may promote CLL cell survival and proliferation. A role for T helper (Th) cells has been suggested, but current evidence is only ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78897ca809dcf38722169c31be597e0e
Autor:
Ludvig A. Munthe, Audun Os, Dong Wang, Anna Parente-Ribes, Bjarne Bogen, Simone Bürgler, Kjetil Taskén, Sigrid S. Skånland, Geir E. Tjønnfjord
Publikováno v:
Haematologica
BCR signaling pathway inhibitors such as Syk inhibitors[1][1]–[3][2] have shown promise in CLL, a mature B cell cancer where the BCR pathway is constitutively active.[4][3] However, sustained BCR signaling can lead to anergy and apoptosis in a proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d591396f25d7409aac63862a52023539
https://pubmed.ncbi.nlm.nih.gov/26589914
https://pubmed.ncbi.nlm.nih.gov/26589914
Autor:
Aleix Gimeno, Stephen Devereux, Anna Parente-Ribes, Audun Os, Bjarne Bogen, Simone Bürgler, Ludvig A. Munthe, Geir E. Tjønnfjord, Dong Wang, Peter Jebsen
Publikováno v:
Journal of immunology (Baltimore Md. : 1950)
Chronic lymphocytic leukemia (CLL) is a B cell malignancy associated with increased levels of inflammatory cytokines. Similarly, expression of CD38 on CLL cells correlates with CLL cell survival and proliferation, but the mechanisms that regulate CD3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b226b2ac4b663f72dbed77daabaefb3
https://pubmed.ncbi.nlm.nih.gov/25505279
https://pubmed.ncbi.nlm.nih.gov/25505279